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Large numbers of protein expression changes are usually observed in mouse models for neurodegenerative diseases, even
when only a single gene was mutated in each case. To study the effect of gene dose alterations on the cellular proteome, we
carried out a proteomic investigation on murine embryonic stem cells that either overexpressed individual genes or displayed
aneuploidy over a genomic region encompassing 14 genes. The number of variant proteins detected per cell line ranged
between 70 and 110, and did not correlate with the number of modified genes. In cell lines with single gene mutations, up and
down-regulated proteins were always in balance in comparison to parental cell lines regarding number as well as
concentration of differentially expressed proteins. In contrast, dose alteration of 14 genes resulted in an unequal number of up
and down-regulated proteins, though the balance was kept at the level of protein concentration. We propose that the
observed protein changes might partially be explained by a proteomic network response. Hence, we hypothesize the existence
of a class of ‘‘balancer’’ proteins within the proteomic network, defined as proteins that buffer or cushion a system, and thus
oppose multiple system disturbances. Through database queries and resilience analysis of the protein interaction network, we
found that potential balancer proteins are of high cellular abundance, possess a low number of direct interaction partners, and
show great allelic variation. Moreover, balancer proteins contribute more heavily to the network entropy, and thus are of high
importance in terms of system resilience. We propose that the ‘‘elasticity’’ of the proteomic regulatory network mediated by
balancer proteins may compensate for changes that occur under diseased conditions.
Citation: Mao L, Zabel C, Herrmann M, Nolden T, Mertes F, et al (2007) Proteomic Shifts in Embryonic Stem Cells with Gene Dose Modifications
Suggest the Presence of Balancer Proteins in Protein Regulatory Networks. PLoS ONE 2(11): e1218. doi:10.1371/journal.pone.0001218
INTRODUCTION
Investigations of etiology and pathogenesis of human diseases are
frequently performed using suitable animals as a model system.
Most commonly mice are employed where a gene of particular
interest is knocked out, mutated or overexpressed. When the effect
caused by genome modification is subsequently studied in these
mice at the molecular level, usually a large number of changes are
observed on the mRNA and protein levels, in spite of the fact that
only a single gene was altered. For example, in protein patterns
obtained by two-dimensional gel electrophoresis (2-DE) of brain
proteins from a mouse model for Parkinson’s disease deficient of
the parkin protein [1] and from a transgenic mouse model for
Huntington’s disease [2], we detected 15 and 40 variant proteins,
respectively [3,4]. Using more sensitive protein detection methods,
such as the differential in-gel electrophoresis (DIGE) technique
and analyzing two different brain regions at two different age
stages, 87 quantitatively variant proteins were detected in the
parkin knock-out mouse [5]. In investigations of a transgenic
mouse model for Alzheimer’s disease that overexpressed mutated
human amyloid precursor protein (App) [6] using our large-gel 2-
DE [7,8] and DIGE technique, we detected more than one
hundred variant proteins (Hartl D. et. al., unpublished results). On
the mRNA level, Miller and colleagues observed over 600 changes
in a single gene modified Parkinson disease mouse model [9].
Similar results were also obtained in other single gene knock-out
mouse models [10].
Apparently, the molecular response to a single gene mutation is
of considerable complexity, and certainly much more complex
than detectable using current experimental approaches. We have
previously compared the protein changes detected in mouse
models for different neurodegenerative diseases and, in addition,
mouse models of non-neurodegenerative disorders [11]. We found
that up to 36% of variant proteins were shared among these
different disease models and hypothesized that these protein
alterations were not disease-specific. Unexpectedly, when we
compared wild-type mice of different inbred strains, we found that
most of these putative disease-unspecific protein alterations also
occurred as polymorphisms that distinguished strains of mice. This
suggested that some, if not most of the protein changes observed
when investigating disease models might not be genuinely
informative regarding etiology or pathogenesis of the disease
under consideration.
To investigate the significance of protein changes under disease
conditions, we have chosen a more systematic and simplified
approach by using mouse embryonic stem (ES) cells with highly
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PLoS ONE | www.plosone.org 1 November 2007 | Issue 11 | e1218defined modifications in a controlled environment. Six mutant cell
lines were investigated. All of them contained gene modifications
relevant to neurodegenerative diseases. Four cell lines contained
one single overexpressed gene, i.e. App (a cell surface receptor),
Snca with changes relevant to Alzheimer’s and Parkinson’s disease,
respectively [9,12] and Dyrk1a (a nuclear kinase) as well as Dopey2
(a leucine zipper-like protein) both relevant to Down syndrome
[13,14]. In two other cell lines, a segment encompassing 14 genes
relevant to Down syndrome was duplicated (trisomic) in one case
and deleted (monosomic) in the other [15]. The six mutant cell
lines were investigated by 2-DE and altered protein expression was
recorded by comparison with the respective parental lines. Many
variant proteins showing up or down-regulation were observed.
Profound quantitative analysis of protein changes led us to the
hypothesis that the cellular proteome is kept quantitatively in
balance by a particular class of proteins to which we refer as
‘‘balancer proteins’’. Accordingly, we assume that when the
quantitative arrangement of the proteome is perturbed by gene
dosage effects, it will be subjected to a rearrangement in order to
achieve a new balance. Thus, the many protein changes observed
may reflect the rearrangement of the proteome to protect the cell
from deleterious effects of gene dosage mutations.
RESULTS
Proteins expressed in ES cells were separated by large-gel 2-DE.
On a representative 2-DE pattern of total protein extract from ES
cells, a total of 4958 protein spots could be scored visually
(Figure 1). Using Delta2D imaging software (see Methods), over
5500 protein spots were detected. Six different transgenic cell lines
were investigated in this study. These comprised two cell lines in
which one single gene was duplicated (mES_Dyrk1a_Tris or
mES_Dopey2_Tris), and two cell lines in which one gene was
overexpressed (5.5 times more than wild-type in mES_hAPP or 1.6
times in mES_Snca). In two cell lines gene dosage was altered over
a chromosomal region that spanned 14 genes on mouse
chromosome 17. A hemizygous deletion line was monosomic for
the interval (mES_14_Mono). The other line contained an
engineered duplication of the segment, and thus was trisomic
(mES_14_Tris). No difference was observed between transgenic
and parental cell lines with respect to cellular morphology and
growth behavior. The six cell lines were compared to their
parental cell lines with regard to their protein expression profiles.
The number of proteins that showed significantly increased or
decreased expression, when compared to their expression in
parental cell lines, was in the range of 70 to 110 variants per cell
Figure 1. Representative protein expression pattern of mouse embryonic cell lines as revealed by large-gel 2D-electrophoresis. Over 5500
proteins (including protein isoforms) were resolved on a single gel. Highlighted spots correspond to spot ID of candidate balancer proteins detailed
in Table 2.
doi:10.1371/journal.pone.0001218.g001
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PLoS ONE | www.plosone.org 2 November 2007 | Issue 11 | e1218line (Table 1). In total, 255 distinct variant proteins were observed
in the six cell lines (Table S1). The data-adjusted modified t-test
SAM (Significance Analysis of Microarrays) was used to calculate
that the false discovery rate for obtaining a comparable result was
less than 1 %.
In the four cell lines that overexpressed a single gene, 40 to 50
proteins were up-regulated. This was always accompanied by
a similar number of down-regulated proteins. A quite different
situation was found for the two cell lines with the dosage alteration
in 14 genes: If duplicated, 60% of proteins were up-regulated and
40% were down-regulated (40%). In case of deletion, a similar
imbalance was found, but in the opposite direction, i.e. about 60%
of the variant proteins showed decreased expression, while only
about 40% were over-expressed (Figure 2A). The observations
described above were based on the number of proteins showing
altered expression profiles in the transgenic cell lines. In the next
step, we investigated the total protein amount showing altered
expression within each cell line by determining relative protein
concentrations (protein spot volumes) across all altered proteins.
This resulted in a balanced picture, i.e. no significant difference
could be detected in the protein amount undergoing up and down-
regulation (Figure 2B). Most importantly, this was even true for the
two cell lines with 14 genes altered, which showed a drastic
imbalance in the number of proteins that underwent up or down-
regulation (see above).
When we compared proteins that showed quantitative changes
among the six cell lines, we found that many of these proteins were
altered in several cell lines. Specifically, 38 proteins showed
changes in more than three cell lines. Among them, the expression
of three proteins changed in all six cell lines, eight proteins
changed in five, while 27 proteins changed in four of six different
transgenic ES cell lines. In contrast, 114 proteins were altered only
in one cell line. In order to test to which extent changes of
expression in the same proteins may occur by chance in multiple
cell lines independently, the numbers of observed co-changed
proteins in different numbers of cell lines were compared to
theoretical numbers of co-changed proteins, assuming that a total
of 800 protein spots were investigated, among which 10% were
differentially expressed in transgenic and control cell lines
(Figure 3). Our calculation showed that the occurrence of the
same protein alteration in more than three cell lines was unlikely to
be coincidental (p,0.001).
An interesting observation was made when we considered
proteins that were only altered in both mES_14_Mono and
mES_14_Tris: Two thirds of them showed the same change
tendency, i.e., either up-regulated in both cell lines, or down-
regulated in both cell lines, despite opposite gene dose alteration
(trisomy versus monosomy). This suggested that many changes
could be unrelated with respect to the gene(s) that caused the
dosage imbalance. Hence, we hypothesize that the proteins
showing changes in several cell lines (38 proteins, see above)
represent a particular class of proteins, which we propose to call
‘‘balancer’’ proteins (Table 2). Different from that, proteins that
were altered only in a single cell line are called here ‘‘cell line-
specific proteins’’ to denote protein alterations specific to a cell line
characterized by a distinct genetic alteration (114 proteins, see
above).
Among the candidate balancer proteins, seven of them were
always increased in their expression in our experiment (Table 2).
They are: Atp6v1c1, Ccdc25, Eno1, Nudt16l1, Psmb7, Ranbp5 and
S100a11. On the other hand, three balancer proteins (Bat2d, Psmb6
and Tceb2) were consistently down-regulated in their expression.
One protein (Psme1) was down-regulated in three cell lines with
transgene overexpression (mES_14_Tris, mES_Dyrk1a_Tris and
mES_Snca), while it was up-regulated in mES_14_Mono.T o
determine whether putative balancer or cell line-specific proteins
might be direct interaction partners of genes mutated in the six cell
lines, we queried all mutated genes, balancer proteins and cell line-
specific proteins in the KEGG pathway database. No overlapping
KEGG pathway entries were detected between balancers and
mutated genes. On the contrary, four KEGG pathway terms of
cell line-specific protein overlapped with that of mutated genes in
our six ES cell lines. These included methionine metabolism,
selenoamino acid metabolism, ABC transporters and purine
metabolism. Similar conclusions could be drawn from Biocarta
pathway database queries.
In order to investigate whether balancers and cell line-specific
proteins might represent two different classes of proteins with
certain biochemical and biophysical properties, we compared
these two sets according to different parameters. The spectrum of
biochemical and biophysical criteria selected for characterization
included molecular weight, isoelectric point, predicted protein
instability, aliphatic index, hydrophobicity, cellular abundance,
polymorphisms (i.e. allelic diversity) and number of direct protein
interaction partners. As summarized in Table 3, balancers and cell
line-specific proteins showed no perceivable difference in their
molecular weights and isoelectric points, neither in their instability,
nor regarding aliphatic index or hydrophobicity. However,
balancer proteins were significantly more abundant in the cell
(p=0.008). Furthermore, cell line-specific proteins were found to
have twice as many interaction partners as balancer proteins
(p=0.004) (Figure 4B). We then queried the Mouse Genome
Informatics Database (www.informatics.jax.org) for the occurrence
of single nucleotide polymorphisms (SNPs) in balancer and cell
line-specific proteins as a measure of their allelic diversity.
Interestingly, the potential balancers had significantly more non-
synonymous SNPs in coding regions than potential cell line-
specific proteins (Table 3), while no significant difference could be
established for other SNP evaluations (total number of SNPs,
proportion of synonymous SNPs in the coding regions and the
frequency of SNPs in the 59-UTR, 39-UTR, introns and sequences
flanking upstream and downstream of a locus).
To assign functional categories, a Gene Ontology (GO) term
enrichment analysis was performed. Tables 4 and 5 give
Table 1. Number of quantitatively variant proteins in six transgenic mouse embryonic stem cell lines.
..................................................................................................................................................
Quantitative changes Number of variant proteins in different transgenic cell lines
mES_14_Mono* mES_14_Tris* mES_Dopey2_Tris mES_Dyrk1a_Tris mES_hAPP mES_Snca
Up-regulated 44 44 37 41 46 52
Down-regulated 62 26 45 37 47 57
Total 1 0 6 7 0 8 27 89 3 1 0 9
*The segment from mouse chromosome 17 includes 14 genes.
doi:10.1371/journal.pone.0001218.t001
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PLoS ONE | www.plosone.org 3 November 2007 | Issue 11 | e1218a summary of GO-terms that occurred more frequently in
balancers or cell line-specific proteins, respectively, based on
human GOA database searches (see Methods for details). Eight
GO-terms were specifically over-represented in balancer candi-
dates. They comprise protein degradation, disulfide modification
and electron carrier processes. In contrast, over 33 GO-terms were
enriched in cell line-specific proteins. Notably, a large part of them
were involved in mRNA processing and related functions. These
two GO-term sets overlap by participating in protein chaperoning
of catabolism processes.
Next, we undertook an analysis of protein-protein interactions
that balancer and cell line-specific proteins participate in, chiefly
based on the Human Reference Protein Database (see methods for
details). The protein-protein interaction graph constructed from
our ES cell data comprised 2677 nodes (distinct proteins, indicated
by gene symbol). This interaction graph shared the common
feature of scale-free geometry with other protein interaction
networks, such as that of E. coli or Saccharomyces cerevisiae [16,17].
Among all protein nodes, 2565 (96%) of them could be linked to
a giant network component with heterogeneous degree distribu-
tion. The remaining 112 proteins formed 41 isolated components,
with the number of nodes varying from one to twelve. Figure 5
shows a subset of the protein-protein interaction network centered
around the proteasome subunits. In the entropy analysis of the
network, we focused on the giant network component, since the
network entropy is only defined for the strongly connected
components of the network. All 38 balancer proteins belonged
to the giant network component, as well as 79 out of 114 cell line-
specific proteins.
As network entropy is a measure of system homeostasis, we may
expect high-ranking proteins to be affected more frequently as the
cell responds to various stimuli. Through a direct comparison of
balancers to cell line-specific proteins using their entropic
Figure 2. Proteins that showed altered expression in transgenic ES cell lines. (A) Number of altered proteins in each transgenic cell line, expressed
as percentile of total number of altered proteins. (B) Amount of proteins that underwent altered expression in each cell line, represented as percent
of total spot volume that was up or down-regulated in transgenic cell lines. Dose alteration of 14 genes could no longer be balanced by an equivalent
number of variant proteins. However, a balance remained at the level of protein concentration.
doi:10.1371/journal.pone.0001218.g002
Figure 3. Comparison of observed number of co-changed proteins
against a theoretical calculation of co-changed proteins across six
different transgenic cell lines. It was assumed that a total of 800
protein spots were investigated, among which 10% of the proteins
change in their expression profile. This comparison shows that the
occurrence of the same protein alteration in more than three cell lines is
unlikely to be coincidental.
doi:10.1371/journal.pone.0001218.g003
Balancing Proteomic Networks
PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1218contribution, we found that balancers, on average, possess
significantly higher values of entropic contribution than cell line-
specific proteins (p=0.02, Wilcoxon rank test, Figure 4). Alterna-
tively, we ask to what extent the entropic measurement can
distinguish between cell line-specific proteins and balancers within
the background of all proteins in the giant component. To this
end, we took the same number of top-ranking proteins based on
their entropic contribution and studied their overlap with our 38
balancers or 79 cell line-specific proteins, respectively. Assuming
a hypergeometric distribution over a total of 2526 proteins, this
corresponds to p=0.018 and p=0.094 for balancers and cell line-
specific proteins, respectively. This illustrates that the entropic
ranking of proteins selects balancers preferentially, thus it validates
our previous observation that proteins with high contribution to
network entropy are enriched in the set of balancer proteins.
DISCUSSION
We investigated the effect of gene dosage alterations on the
proteome of mouse embryonic stem (ES) cells. Using our large-gel
2-DE, extraordinary in its high resolution and reproducibility [7],
total protein extracts from six different ES cell lines were analyzed.
In four of them, one single gene was overexpressed either by gene
duplication (Dyrk1a, Dopey2) or by conventional stable gene
Table 2. Proteins changed in more than three transgenic ES cell lines (proposed balancer proteins).
..................................................................................................................................................
Spot ID Protein Name Gene Symbol Behavior
B125 aminolevulinate, delta-, dehydratase Alad 3 q,2 Q
S37 albumin Alb 1 q,3 Q
B40 ATPase, H+ transporting, lysosomal V1 subunit C1 Atp6v1c1 always up
S34 BAT2 domain containing 1 Bat2d always down
B96 carbonic anhydrase 2 Car2 1 q,3 Q
B476 calcium response factor Carf 2 q,2Q
B72 coiled-coil domain containing 25 Ccdc25 always up
B178 eukaryotic translation elongation factor 1 alpha 1 Eef1a1 1 q,3 Q
B70 enolase 1, alpha non-neuron Eno1 always up
S10 fatty acid binding protein 3, muscle and heart Fabp3 2 q,4 Q
B110 guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 Gnb2l1 1 q,3 Q
S98 golgi autoantigen, golgin subfamily b, macrogolgin 1 Golgb1 1 q,4 Q
B175 glutamate oxaloacetate transaminase 2, mitochondrial Got2 3 q,1 Q
B121 glyoxylate reductase/hydroxypyruvate reductase Grhpr 3 q,2 Q
S160 histone cell cycle regulation defective interacting protein 5 Nfu1 2 q,2 Q
B154 heterogeneous nuclear ribonucleoprotein A2/B1 Hnrpa2b1 4 q,1 Q
B134 LIM and SH3 protein 1 Lasp1 2 q,4 Q
B123 mitochondrial ribosomal protein L39 Mrpl39 3 q,2 Q
S38 nucleophosmin 1 Npm1 1 q,3 Q
B62 nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 Nudt16l1 always up
B475 polyribonucleotide nucleotidyltransferase 1 Pnpt1 1 q,3 Q
S238 pyrophosphatase (inorganic) 1 Ppa1 2 q,2 Q
B45 PPAR-alpha interacting complex protein 285 Pric285 4 q,1 Q
S557 proteasome (prosome, macropain) subunit, beta type 6 Psmb6 always down
B77 proteasome (prosome, macropain) subunit, beta type 7 Psmb7 always up
S90 proteasome (prosome, macropain) 28 subunit, alpha Psme1 1 q,3 Q
B43 RAN binding protein 5 Ranbp5 always up
S6 S100 calcium binding protein A11 (calgizzarin) S100a11 always up
B203 serine (or cysteine) peptidase inhibitor, clade H, member 1 Serpinh1 1 q,3 Q
B422 single-stranded DNA binding protein 1 Ssbp1 2 q,2 Q
B50 transgelin Tagln 1 q,3 Q
B124 transaldolase 1 Taldo1 3 q,2 Q
S32 transcription elongation factor B (SIII), polypeptide 2 Tceb2 always down
S204 thimet oligopeptidase 1 Thop1 1 q,3 Q
S100 tropomyosin 1, alpha Tpm1 1 q,4 Q
S395 Thioredoxin-like 2 Txn1 2 q,2 Q
S4 Thioredoxin 1 Txn1 2 q,2 Q
S99 Thioredoxin-related protein Txnl1 2 q,2 Q
doi:10.1371/journal.pone.0001218.t002
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PLoS ONE | www.plosone.org 5 November 2007 | Issue 11 | e1218transfection (App, Snca). In two other cell lines, the dosage of
a whole set of 14 genes was altered so that the segment was either
duplicated (trisomic) or deleted (monosomic). According to our
observations, dose alteration of a single gene led to quantitative
changesin alargenumberofproteins.Surprisinglyhowever,altering
the dosage of 14 genes instead of one gene did not increase the
number of altered proteins accordingly. In effect, the frequency of
protein variations induced by one or 14 altered gene dosages was in
a similar range. Hence, we propose that the protein changes
observed might not completely reflect reactions of proteins
functionally linked with the genes whose dosage was altered. Rather,
these changes may at least be partially explained as a global response
of the cellular proteome to the gene dosage defect.
Considering the protein changes observed in our ES cell lines in
more detail, we found that in all cases where a single gene was
overexpressed, the number of proteins which were up-regulated
was always in equilibrium with the number of down-regulated
proteins (Figure 2A). Moreover, when we measured up and down-
regulation of proteins in terms of protein amount instead of
number of proteins, a balance in up and down-regulation was also
observed. The situation was different in the two cell lines carrying
alterations in 14 genes. Here, the number of proteins up or down-
regulated was no longer in equilibrium: In mES_14_Tris, about
60% of the altered proteins were up-regulated, whereas about
40% of the proteins were down-regulated. The changes in the
mES_14_Mono showed the same ratio, but in reversed direction
(ca. 60% down, 40% up). However, regarding the protein
variations at the level of protein amount, a balance reoccurred
even in cell lines with 14 genes altered (Figure 2B).
We therefore hypothesize the existence of a proteome-wide
acting regulatory mechanism that leads to a compensation of an
imbalance in the quantitative arrangement of the cellular
proteome. Within the proteome of a cell, the relative concentra-
tion of each particular protein should be precisely arranged and
well balanced. In consequence, aberrant quantitative changes,
even in a single protein, may alter the relative concentration of
many other proteins, thereby disturbing the overall proteomic
balance. In this situation, the first response of the cell could be
towards restoring the balance in the cellular proteome in order to
maintain normal cellular operations. As a result, below certain
thresholds, a rebuild of system homeostasis by quantitative
rearrangement of the proteome may be achieved.
Several considerations that originate from theoretical biology
and experimental model systems are in line with our hypothesis
outlined above: The theory of protein minimization [18] states
that all protein levels within a cell are maintained at the minimum
level compatible with function, while metabolic pathway fluxes are
maintained at the maximum. This is explained as a consequence
of an increasing number of proteins occurring in the course of
evolution, e.g. by gene duplication, that needed to be accommo-
dated in the cells. Since the resources of a cell (such as space,
energy, metabolites e.g. amino acids and unbound water to allow
diffusion) did not increase accordingly, the occurrence of new
proteins in evolution was always accompanied by a concentration
reduction of proteins that already present. In order to keep cellular
functions intact in spite of protein concentration reduction, the
functional efficiency of the already established proteins (e.g. the
specific activity of enzymes) had to increase. Another theory, the
excluded volume theory established by A.P. Minton [19,20] deals
with the high degree of macromolecular crowding in cells. If
a protein is overexpressed in a cell, movement of this and
surrounding proteins becomes restricted due to excluded volume.
Thus the distance between protein molecules becomes smaller
than the diameter of moving protein molecules. Proteins react to
this situation with conformational changes and tend to aggregate
and to lose their function. Apparently, active or passive regulatory
mechanisms exist that keep the cellular protein concentrations
within a physiologically buffered range.
When the relative cellular proteome composition is disturbed,
probably not all proteins are changed in their quantitative
Table 3. Comparison of protein properties of balancer and cell line-specific proteins.
..................................................................................................................................................
Protein properties Balancers Cell line-specific proteins p-value
Molecular weight (kD) 47.2642.5 48.3647.3 0.906
Isoelectric point 6.5261.68 6.9861.71 0.14
Instability 41.3612.8 41.8611.2 0.81
Aliphatic index 79.7614.2 77.7616.8 0.51
Gravy score 20.44960.337 20.44460.357 0.94
Cellular abundance (% volume of protein spot) 0.15860.169 0.11860.116 0.0082
No. of interaction partners
(3) 4.9 7.8 0.0048
Total No. of SNPs per locus 29.5640.1 30.6658.7 0.46
No. of upstream SNPs
(1) 2.764.7 1.964.9 0.53
No. of SNPs in 59-UTR 1.062.3 1.964.9 0.76
No. of SNPs in introns 18.8631.3 20.5648.1 0.43
No. of synonymous SNPs in ORF 1.363.1 1.460.5 0.12
No. of nonsynonymous SNPs in ORF 2.861.83 0.761.8 0.026
No. of SNPs in 39-UTR 2.164.6 1.163.2 0.0855
No. of SNPs downstream
(2) 2.665.4 3.265.3 0.89
Entropic contribution
(3) 1.51 0.97 0.02
Values in bold indicate significant difference between balancer and cell line-specific proteins
(1)Interval up to a position 2000 bp upstream of the transcription start site
(2)Interval from polyadenylation site to a position 2000 bp downstream
(3)Standard errors not shown since the distributions are tend to be screwed.
doi:10.1371/journal.pone.0001218.t003
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PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1218occurrence to the same extent. Regarding our hypothesis, we
suggest the existence of a special class of proteins that are
particularly effective in such rebalancing approaches. This led us
to propose discrimination between balancer and cell line-specific
proteins. We hypothesize that balancers are proteins that buffer or
cushion a cellular system by common properties, i.e., properties
not necessarily related to their specific functions. Accordingly, the
same proteins may change when different system disturbances
have caused protein imbalance. In line with these definitions, we
found no considerable overlapping functions between balancer
proteins and the transgenes. In contrast, the expression alterations
of cell line-specific proteins could more likely have been directly
induced by gene dosage modifications. This finding further
supports the notion that the changes of balancer proteins represent
more peripheral cellular affairs.
To find out whether balancer proteins might have further
distinct properties, we analyzed them using multiple categories
outlined in tables 3, 4 and 5. We found that potential balancers
seem to be of high cellular abundance. This is plausible as very low
abundance proteins (e.g. regulatory proteins, transcription factors
and receptors) are possibly present only in a few copies per cell and
thus have no real buffer capacity to compensate imbalance at the
proteomic scale. In retrospect, it is known that all proteins visible
on 2-DE patterns are relatively abundant [21]. Still, even under
these preconditions, balancer proteins seem to be more abundant
than cell line-specific proteins. Moreover, potential balancers
turned out to be more polymorphic in their coding regions than
cell line-specific proteins. Protein polymorphisms indicate proteins
which became less constrained in the course of evolution [22]. As
a consequence, proteins bearing a higher degree of polymorphisms
(including balancers) may tend to be more flexible in quantitative
changes, whereas cell line-specific proteins may require a stronger
connection between expression level and function.
Another trait of our candidates for balancer proteins was found
by screening a protein-protein interaction database available online
(HPRD). Here, balancers possessed less direct interaction partners
than cell line-specific proteins. Interestingly, in the protein in-
teraction network published by Stelzl et al. for human proteins [23],
disease-related proteins annotated in the Online Mendelian Inheritance in
Man database (OMIM)were located almostexclusively inthe area of
low connective level. This correlation may indicate a particular role
of balancer proteins in diseases conditions, but at the same time
raises our suspicion that balancer proteins are more likely to be
identified as disease-associated proteins partially due to their
frequent and reproducible alterations.
Towards understanding how balancer proteins in their
functional properties may impart elasticity to the proteomic
Figure 4. Cumulative fraction plots of ‘‘balancer’’-‘‘cell line-specific
protein’’ comparison. (A) Entropic contribution.; (B) Number of direct
protein interaction partners. Compared to cell line-specific proteins,
balancers possess significantly higher values of entropic contribution
and a low number of direct interaction partners.
doi:10.1371/journal.pone.0001218.g004
Table 4. GO-terms enriched among balancer proteins detected in the proteome of mouse ES cells.
..................................................................................................................................................
GO-ID Count
1 Total
# p-Value GO-term Category*
GO:0009056 7 877 0.002 catabolism BP
GO:0006091 7 1028 0.003 generation of precursor metabolites and energy BP
GO:0030508 2 5 0.001 thiol-disulfide exchange intermediate activity MF
GO:0015035 3 73 0.003 protein disulfide oxidoreductase activity MF
GO:0016836 3 81 0.003 hydro-lyase activity MF
GO:0016835 3 92 0.004 carbon-oxygen lyase activity MF
GO:0015036 3 96 0.004 disulfide oxidoreductase activity MF
GO:0009055 4 289 0.007 electron carrier activity MF
1Number of balancer proteins bearing this GO-term.
#Total number of proteins in the human GOA database annotated with this GO-term.
*BP: biological process; MF: Molecular function.
doi:10.1371/journal.pone.0001218.t004
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PLoS ONE | www.plosone.org 7 November 2007 | Issue 11 | e1218system, we queried what kind of shared functional categories these
proteins may possess (biological process and molecular function
GO terms). Compared to the candidate balancers, cell line-specific
proteins were associated with a much broader spectrum of GO-
categories (Table 4 and 5). In addition, cell line-specific proteins
but not balancers were highly involved in mRNA-related
processes. This is in line with the fact that these processes are
tightly regulated. Proteins involved therein are thus prone to
concentration alteration, a property incompatible with a role as
balancers. Moreover, our set of putative balancer proteins was
enriched in stress and metabolic proteins compared to the
remaining proteins altered. The physiological activity of a signif-
icant subset of cellular proteins is modified by the redox state of
regulatory thiol groups. The cellular redox homeostasis depends
on the balance between oxidation of thiols through oxygen and
reactive oxygen species and reduction by thiol-disulfide transfer
reactions. In this respect, it would make sense that potential
balancer proteins are enriched in GO categories implicated in
disulfide oxidoreductase and thiol disulfide exchange.
One particularly important feature of a living system is its
resilience against external and internal changes, which, at the
molecular level, amounts to perturbations in network parameters.
In an attempt to analyze this robustness of the cellular system, we
applied a network analysis, which is motivated by concepts from
statistical mechanics and dynamical systems theory. Our approach
is based on the assumption that biological processes often operate
at steady state, which corresponds to the observed phenotype [24].
It has been shown that changes in network entropy, a fundamental
statistical property, are positively correlated with system robust-
ness. In turn, the entropic contribution of a protein describes its
impact on network integrity. Removal of nodes with high entropic
contribution more often result in lethal phenotypes from yeast and
Table 5. Enriched GO-terms among cell line-specific proteins detected in the proteome of mouse embryonic stem cells.
..................................................................................................................................................
GO-ID Count
1 Total
# p-Value GO-term Category*
GO:0043170 41 7475 7.85E-07 macromolecule metabolism BP
GO:0006396 11 503 3.49E-06 RNA processing BP
GO:0044238 53 11859 3.83E-06 primary metabolism BP
GO:0016070 12 662 4.71E-06 RNA metabolism BP
GO:0008152 57 13425 4.76E-06 metabolism BP
GO:0008614 2 2 1.72E-04 pyridoxine metabolism BP
GO:0008615 2 2 1.72E-04 pyridoxine biosynthesis BP
GO:0042816 2 2 1.72E-04 vitamin B6 metabolism BP
GO:0042819 2 2 1.72E-04 vitamin B6 biosynthesis BP
GO:0043283 24 4377 0.001 biopolymer metabolism BP
GO:0006139 27 5422 0.002 nucleobase, nucleoside, nucleotide and nucleic acid metabolism BP
GO:0016071 6 292 0.002 mRNA metabolism BP
GO:0006397 5 243 0.006 mRNA processing BP
GO:0006511 5 248 0.006 ubiquitin-dependent protein catabolism BP
GO:0019941 5 248 0.006 modification-dependent protein catabolism BP
GO:0043632 5 248 0.006 modification-dependent macromolecule catabolism BP
GO:0044260 25 5232 0.007 cellular macromolecule metabolism BP
GO:0019538 26 5543 0.007 protein metabolism BP
GO:0000375 4 148 0.007 RNA splicing, via transesterification reactions BP
GO:0000377 4 148 0.007 RNA splicing, via transesterification BP
GO:0000398 4 148 0.007 nuclear mRNA splicing, via spliceosome BP
GO:0006564 2 16 0.009 L-serine biosynthesis BP
GO:0030530 2 16 0.009 heterogeneous nuclear ribonucleoprotein BP
GO:0044257 5 288 0.009 cellular protein catabolism BP
GO:0051603 5 287 0.009 proteolysis during cellular protein catabolism BP
GO:0003723 14 930 3.83E-06 RNA binding MF
GO:0008266 2 2 1.72E-04 poly(U) binding MF
GO:0016018 2 6 0.002 cyclosporin A binding MF
GO:0050662 5 193 0.002 coenzyme binding MF
GO:0000166 21 3851 0.003 nucleotide binding MF
GO:0048037 5 220 0.004 cofactor binding MF
GO:0003727 2 12 0.006 single-stranded RNA binding MF
GO:0008144 2 17 0.010 drug binding MF
1Number of cell line-specific proteins bearing this GO-term.
#Total number of proteins in the human GOA database annotated with this GO-term.
*BP: biological process; MF: Molecular function.
doi:10.1371/journal.pone.0001218.t005
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PLoS ONE | www.plosone.org 8 November 2007 | Issue 11 | e1218C. elegans [25]. Our ranking analysis shows that there is a difference
between balancers and cell line-specific proteins: Compared to cell
line-specific proteins, balancers possessed a higher entropic
contribution. This structural property suggests that balancers
might be able to attenuate system disturbance more efficiently.
The existence of balancer proteins could therefore be responsible
for the elasticity of a cellular system.
For example, a number of proteins representing proteasome
subunits showed altered expression in our transgenic cell lines.
Five of them belong to balancer candidates, while three other
proteasome subunits belong to cell line-specific proteins. Consid-
ering the proteasome sub-interaction network in detail (Figure 5),
we noticed that Psma2 and Psma3, which are local hubs in the
subgraph, both belong to candidate cell line-specific proteins. On
the other hand, Psmb6 is a candidate balancer protein connecting
between two different nodes of a higher order. This example
supports our assumption that balancer proteins could be
connective hubs between different modules. Such ‘‘bridges’’ are
probably heavily utilized during balancing processes. It is worth
noting that the concept of ‘‘bridges’’ discussed here resembles that
of ‘‘high betweenness’’ of previous studies on protein interaction
networks using graph theory [26,27]. If two clusters of interacting
proteins are joined together only through a mutual interacting
protein, this protein would have a ‘‘high betweeness’’ measure.
‘‘High betweeness’’ thus indicates the importance of a node within
the wider context of the holistic network [27]. Here, the entropic
contribution captures this property not in terms of shortest pats (as
betweenness), but in terms of random walks inside the network. In
this sense, network entropy and entropic contribution provide
a conceptual framework to understand the role of the heuristic
centrality indices, such as node degree and betweenness.
We are aware that our conclusion provides only one qualitative
interpretation of the experimental observations. Under the
assumption that gene dosage modifications in the ES cell lines
represent small perturbations to the cellular system, more detailed
theoretical interpretations can also be sought. For example,
previous studies have described that cellular fates such as
differentiation, growth, quiescence, or apoptosis may represent
the convergence of stochastic cellular program onto a small set of
common self-stabilizing ‘‘attractors’’ states [28–30]. These attrac-
tor states, which are robust to small perturbations, may also
explain our observation that the transgenic ES cells remained in
their original steady state as undifferentiated ES cells. However,
we are cautious with respect to such a general conclusion,
considering that our sample set is very limited, both in terms of
sample dimension and its representative nature. Importantly, most
of the current network data is of purely structural character, and
does not allow for a more detailed understanding of the underlying
dynamics, or even its logical abstraction. Moreover, the protein
property information was obtained from current protein database
entries that are incomplete and may be biased towards intensively
studied proteins. Furthermore, due to our small sample sizes, the
p-value estimations are not very robust, and may affect our
assignment of significance for observed differences. Possible future
experiments to test our hypothesis could be, for example, to
analyze transgenic cell lines overexpressing one of the candidate
balancer proteins in the same in vitro system.
In summary, based on our results we hypothesize that the large
number of variant proteins detected in mutant ES cells does not
necessarily reflect disease-related dysfunctions of these proteins,
but rather a quantitative rearrangement of the proteome in
response to a disturbance induced by gene dosage alterations. We
postulated a regulatory mechanism established in a cell that
protects it from deleterious effects of mutations by keeping the
macromolecular composition of a cell quantitatively in balance.
MATERIALS AND METHODS
Transgenic ES cell line construction
Pluripotent mouse ES cells were genetically manipulated on single
or a set of genes involved in neurodegenerative diseases. A
plasmid-mediated gene insertion protocol was used to generate
App and Snca-overexpressing cell lines (mES_hAPP and mES_Snca,
respectively), with CGR8 as parental line [31,32]. For this
purpose, a transfer vector based on pMSCV (BD BioSciences
Clontech Heidelberg, Germany), which contained a puromycin
resistance gene, was modified by inserting a 1.3 kb fragment of the
rat promoter for translation elongation factor 1 alpha 1 (Eef1a1).
This promoter has been shown to be suitable for protein
overexpression in ES cells [33]. cDNA of a target gene (human
App or mouse Snca) was inserted in frame with the initiating
methionine specified by the rat Eef1a1 promoter. The vector was
electroporated into the ES cells at standard conditions (250V,
500 mF). 24h after electroporation, seven days of puromycin
selection followed to select stably transformed ES cell lines.
Western blotting was carried out to confirm protein overexpres-
sion (monoclonal mouse IgG against human amyloid b peptide,
amino acids 1–17, clone 6E10; monoclonal mouse IgG against a-
synuclein, clone 5D6, Signet Laboratories, Berkeley, USA). The
MICER strategy was used to generate ES cell lines bearing
segmental deletion or duplication of Abcg1-U2af1 on mouse
chromosome 17 (30333543 to 31387432 bp), using ES cell line
HM-1 as parental line [13,15,34,35] (mES_14_Mono and
mES_14_Tris, respectively). This chromosome segment contains
the following genes: Abcg1, Tff3, Tff2, Tff1, Tmprss3, Ubash3a,
Figure 5. A protein-protein interaction subgraph showing the
proteasome subunits, where nodes denote proteins and the edges
describe protein-protein interaction. Two local hub proteins of this
subgraph (Psma2 and Psma3) belong to cell line-specific proteins, while
a candidate balancer protein (Psmb6) represents a connection between
these two modules (see discussion for details). This supports our
assumption that balancer proteins could be connective hubs between
different modules. Protein marked in green: Psma2; yellow: Psmb6;
magenta: Psma3.
doi:10.1371/journal.pone.0001218.g005
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Cbs and LOC623242. The bordering gene Abcg1 was deleted in the
monosomy, but unaffected in the trisomy cell line. ES cell lines
trisomic for murine Dyrk1a (mES_Dyrk1a_Tris) or murine Dopey2
(mES_Dopey2_Tris) were generated using a BAC gene transfer
protocol [36], with D3 as parental cell line (for Dyrk1a: BAC
189N10 from the CT7 library, pBeloBac11 vector, 94672437 to
94823558 bp on MMU16; for Dopey2: PAC 186P4 from the RP21
library, pPAC4 vector, 93576842 to 93751423 bp on MMU16)
[37]. All ES cell lines were able to give germ-line transmission
[14,15], except for the CGR8 subclone used, which is primarily
intended for work in vitro (Savatier, personal communication).
Maintenance of ES cells
ES cell lines were grown in Dulbecco’s Modified Eagle Medium
(DMEM; Invitrogen, Karlsruhe, Germany) supplemented with
15% fetal calf serum (Biochrom, Berlin Germany), 2mM L-
glutamine (Invitrogen), 0.1mM non-essential amino acids (Invitro-
gen), 1mM sodium pyruvate (Invitrogen), 0.1 mM 2-mercap-
toethanol (Invitrogen) and 100U/ml leukemia inhibitory factor
(LIF, Chemicon, Hampshire UK) under standard cell culture
conditions (37uC, 5% CO2, 95% humidity). Modified and control
cell lines were always cultured in parallel. CGR8-derived ES cell
lines were maintained on gelatine-coated (0.1% v/v) cell culture
plates. ES cells with E3 or HM-1 as parental line were maintained
on mitotically inactivated murine embryonic fibroblasts. Prior to
cell harvest, these cells were grown for three further passages on
gelatine-coated plates to eliminate feeder cells. Cells were grown to
70–90% confluence and met morphological criteria for undifferen-
tiated ES cells at the time of harvest (tightly packed cells forming
round colonies). ES cells of three independent 10cm culture dishes
were gently dissociated in ice cold PBS containing 5mM EDTA.
This resulted in three biological replicates for each cell line.
Trypsinization was avoided to preclude protein alteration artifacts.
2D-Electrophoresis
ES cell total protein extraction was carried out using our standard
protocol [8]. 70 mg of protein was separated in each 2-DE-run as
described previously [7]. Transgenic and their parental cell lines
were always run in parallel. Two technical repeats were conducted
for each cellular protein extract. Silver staining protocol was
employed to visualize protein spots [38]. Computer-assisted
manual gel evaluation was performed after scanning of the gel
images (600 dpi, UMAX, Willich Germany) (Delta2D version 3.4,
Decodon, Greifswald Germany) [39]. Briefly, corresponding gel
images were first warped using ‘‘exact mode’’ (manual vector
setting combined with automatic warping). A fusion gel image was
subsequently generated using union mode, which is a weighted
arithmetic mean across the entire gel series. Spot detection was
carried out on this fusion image automatically, followed by manual
spot editing. Subsequently, spots were transferred from fusion
image to all gels. The signal intensities of each spot was computed
as a weighted sum of all pixel intensities (volume of protein spot).
Percent volume of spot intensities calculated as a fraction of the
total spot volume of the parent gel was used for quantitative
analysis of protein expression level. Ninety-five percent of the
protein spots on the 2D gels that did not vary in their
concentration and spot intensity served as reference. Thus, the
balancing phenomenon is not due to a normalization artifact that
could have arisen from global normalization to a mean or median.
Normalized values after local background subtraction were
subsequently exported from Delta2D in spreadsheet format for
statistical analysis.
Mass spectrometric protein identification
For protein identification by mass spectrometry, 2-DE gels were
stained with a mass spectrometry compatible silver staining
protocol [40]. Protein spots of interest were excised from 2-DE
gels and subjected to in-gel trypsin digestion without reduction and
alkylation. Tryptic fragments were analyzed on a LCQ Deca XP
nano HPLC/ESI ion trap mass spectrometer (Thermo Fisher
Scientific, Waltham, MA, USA) as described previously [11]. For
database-assisted protein mass finger printing, monoisotopic mass
values of peptides were searched against NCBI-nr (version
20061206, taxonomy: Mus musculus), allowing one missed cleavage.
Peptide mass tolerance and fragment mass tolerance were set at
0.8 Dalton. Oxidation of methionine and arylamide adducts on
cysteine (propionaide) were considered as variable peptide
modifications. Criteria for positive identification of proteins were
set according to the scoring algorithm delineated in Mascot
(Matrix Science, London, UK) [41], with individual ion score cut-
off threshold corresponding to p,0.05.
Annotation of biochemical properties and
functional categories to proteins
Public database queries were performed for the characterization of
proteins with altered expression profiles in transgenic ES cells. For
this purpose, GOstat (http://gostat.wehi.edu.au) was employed to
annotate and search against the human GOA database (www.ebi.
ac.uk/GOA) in order to determine highly represented functional
categories for our proteins of interests [42]. This tool integrates
a Fisher’s exact test that decides whether the observed GO-term
over-representation is significant. p,0.01 was set as statistical
significance threshold. ProtParam was used to predict the protein
instability, aliphatic index and Gravy scores (www.expasy.org/
tools/protparam). The Human Reference Protein Database (www.
hprd.org) was used to access the number of direct protein
interaction partners. Batch searches of overall protein-protein
interaction network information were performed via the meta-
database UniHi (http://theoderich.fb3.mdc-berlin.de:8080/
unihi). Subsequently, information originating from HPRD, BIND,
DIP and Reactome, which are curated manually, was extracted.
The visualization of the protein interaction network was
performed using Cytoscape (www.cytoscape.org) [43]. The Mouse
Genome informatics database (MGI 3.5) was used to access the
number of SNPs across 86 inbred mouse strains (www.informatics.
jax.org). Biological pathway analyses were performed using
KEGG (www.genome.ad.jp/kegg) and Biocarta pathway data-
bases (www.biocarta.com). Protein abundance information was
extracted from 2-DE data.
Statistics
To assess statistical significance of expression differences between
transgenic and control cell lines, Student’s T-test was carried out
for control vs. transgenic groups (pair-wise, two sided, n=6).
p,0.05 was used as statistical significance threshold. Only protein
expression changes over 30% compared to control were retained
for further analysis. As a post hoc control analysis, protein
expression data generated from 2DE were scrutinized using the
Significance Analysis of Microarrays tool (SAM, www-stat.stan-
ford.edu) to identify the false detective rate required to gain the
comparable set of altered proteins (100 permutations) [44]. Protein
expression alteration (fold change against wild-type controls) was
reported with standard error of means (SEM). Due to their non-
parametric distribution nature, protein property data (protein
cellular abundance, biochemical properties and entropic contri-
bution) were visualized as cumulative fraction plots. Differences of
Balancing Proteomic Networks
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assessed with the Wilcoxon sum rank test (p,0.05).
Network-based approach for system robustness
analysis
Many aspects of cellular behavior are mainly determined by the
structural properties of the underlying molecular network. In order
to characterize the macroscopic resilience properties of the
proteomic system, we adopted a network approach which is based
on molecular protein interactions. This approach utilizes a fluctu-
ation theorem [24], which states that the resilience of macroscoptic
network observables is positively correlated with the pathway
diversity, a property which can be measured by network entropy.
In this context, network entropy appears as the dynamical entropy
of a stochastic process defined on the network, i.e the weighted-
average Shannon entropy, H~
X
i piHi, where pi is the
stationary distribution of the stochastic process (Pij) and Hi is the
standard Shannon entropy defined by:
Hi~{
X
j
PijLogPij
i.e., the uncertainty about the next step of a random walk
operating on the network. The stochastic process, Pij, is defined
through a variational principle for the leading eigenvalue, which,
for unweighted networks, maximizes the overall network entropy
[24]. Thus, ‘‘H’’ denotes the network entropy of the whole protein-
protein interaction network, whereas ‘‘Hi’’ denotes the entropic
contribution of each individual protein (see Methods S1 for
details). This entropic characterization leads to a natural impor-
tance ranking of proteins within the context of resilience of the
global protein interaction network [25]. For this purpose, a pro-
tein-protein interaction network was generated from all proteins
identified from the 2-DE protein pattern of ES cells. This
generates an undirected, un-weighted information transfer graph
where nodes denote proteins and the edges describe protein-
protein interaction. The topological structure of the graph can be
described by an NxN adjacency matrix A=(aij). The entropic
contribution of each protein to the global network entropy was
calculated as in [25].
SUPPORTING INFORMATION
Table S1 Protein expression profile changes in transgenic ES
cell lines.
Found at: doi:10.1371/journal.pone.0001218.s001 (0.11 MB
XLS)
Methods S1 Supplementary method of network entropy
calculation
Found at: doi:10.1371/journal.pone.0001218.s002 (0.05 MB
PDF)
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